Cancer biology research links YAP and TAZ hyperactivation to immune evasion by coupling genomic instability with increased PD-L2 expression. The dataset describes findings that YAP/TAZ-driven instability can expose tumors to immune cells while simultaneously elevating PD-L2 to suppress T-cell attack. The work positions YAP/TAZ as a dual driver of tumor immunogenicity and immune checkpoint upregulation, supporting combined targeting strategies in future preclinical or translational work. No clinical trial endpoints were provided in the dataset.
Get the Daily Brief